Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.

Depression Clinical Trial

Official title:

Implementing an Innovative Suite of Mobile Applications for Depression and Anxiety

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03500536
• Other study ID #: Main
• Status: Completed
• Phase: N/A
• Start date: July 18, 2018
• Est. completion date: April 4, 2019

Study information

• Verified date: April 2019
• Source: Actualize Therapy
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, cost-effectiveness, and usability of mobile apps.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 146
• Est. completion date: April 4, 2019
• Est. primary completion date: April 4, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Positive screen on PHQ-9

Exclusion Criteria:

• Does not own or use a mobile smart phone

Related Conditions & MeSH terms

• Anxiety
• Depression
• Depressive Disorder
• Primary Health Care

Intervention

Behavioral:
• IntelliCare
A suite of mobile apps that use principles of computerized therapy to decrease symptoms of depression.

Locations

Country	Name	City	State
United States	University of Arkansas for Medical Sciences	Little Rock	Arkansas

Sponsors (2)

Lead Sponsor	Collaborator
Actualize Therapy	University of Arkansas

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Symptoms of depression	Using the PHQ-9 screener	8 weeks